ADAGIO MEDICAL HOLDINGS, INC COMMON STOCK (NASDAQ: ADGM)

ADAGIO MEDICAL HOLDINGS, INC COMMON STOCK

NASDAQ: ADGM (Adagio Medical Holdings, Inc)

Kemas kini terakhir: 25 Nov, 12:49AM

0.799

0.01 (1.14%)

Tambah ke senarai pantauan

Penutupan Terdahulu	0.790
Buka	0.784
Jumlah Dagangan	69,492
Purata Dagangan (3B)	358,747
Modal Pasaran	16,922,530

Harga / Jualan (P/S)	205.85
Harga / Buku (P/B)	3.57

Julat 52 Minggu

0.625 (-21%) — 2.87 (259%)

Arah Aliran Pasaran

		Jangka Pendek	Jangka Sederhana
Industri	Medical Devices (US)	Bercampur	Bercampur
	Medical Devices (Global)	Bercampur	Bercampur
Stok	Adagio Medical Holdings, Inc	-	-

AISkor Stockmoo

0.5

Konsensus Penganalisis	2.5
Aktiviti Orang Dalam	NA
Volatiliti Harga	0.5
Purata Bergerak Teknikal	1.0
Osilator Teknikal	-2.0
Purata	0.50

Saham Serupa

Stok	Modal Pasaran	DY	P/E (TTM)	P/B
ADGM	17 M	-	-	3.57
CBLL	630 M	-	-	3.83
MGRM	244 M	-	-	-
BDMD	52 M	-	2.88	1.52
DHAI	2 M	-	-	3.03
DXCM	26 B	-	36.38	9.28

Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.
Sektor	Healthcare
Industri	Medical Devices
% Dimiliki oleh Orang Dalam	0.29%
% Dimiliki oleh Institusi	85.46%

Julat 52 Minggu	0.625 (-21%) — 2.87 (259%)
Median	4.00 (400.63%)
Jumlah	1 Beli

Syarikat	Tarikh	Harga Sasaran	Panggilan	Harga @ Panggilan
Lake Street	02 Dec 2025	4.00 (400.63%)	Beli	0.908

Tiada data dalam julat masa ini.

Tarikh	Jenis	Butiran
12 Nov 2025	Pengumuman	Adagio Medical Reports Third Quarter 2025 Results
05 Nov 2025	Pengumuman	Adagio Medical to Present at the Piper Sandler 37th Annual Healthcare Conference
20 Oct 2025	Pengumuman	Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia
15 Oct 2025	Pengumuman	Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities
10 Oct 2025	Pengumuman	Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium
01 Oct 2025	Pengumuman	Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia
18 Sep 2025	Pengumuman	Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium
08 Sep 2025	Pengumuman	Adagio Medical Expands Chief Business Officer Deborah Kaster’s Role to Include Chief Financial Officer Responsibilities

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

Log masuk untuk menambahkan ke senarai pantauan

AI Templat

Peringatan harga anda

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Log masuk untuk menambahkan ke senarai pantauan

Keuntungan Nyata	-
Keuntungan Tidak Nyata	-
Dividen Diterima 2025	-
Jumlah Untung	-
Pulangan Purata	-
Kuantiti (Beli)	-
Purata Harga (Beli)	-
Kuantiti (Jual)	-
Purata Harga (Jual)	-

Log masuk untuk menambahkan ke senarai pantauan

Tiada saham yang memenuhi kriteria anda

Margin Operasi (TTM)	-5,822.92%
EPS Cair (TTM)	-3.19
Pertumbuhan Hasil Suku Tahunan (YOY)	75.60%

Jumlah Hutang/Ekuiti (D/E MRQ)	149.87%
Nisbah Semasa (MRQ)	2.89
Aliran Tunai Operasi (OCF TTM)	-29.93 M
Aliran Tunai Bebas Leveraj (LFCF TTM)	-28.82 M

Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)